“Making TauRx’s groundbreaking drug HMTM# accessible to patients with Alzheimer’s Disease under Named Patient Program”
HONG KONG SAR / SINGAPORE – Media OutReach Neswire – 18 January 2024 – ICB Medical Ltd (“ICB“), a member of the Immuno Cure BioTech Group (“Immuno Cure“), is appointed as the exclusive Named Patient Program (“NPP“) Manager, for TauRx’s groundbreaking drug, Hydromethylthionine Mesylate (“HMTM#“), in Hong Kong SAR and Macau SAR (“Territories“) by Poredeen Pte Ltd (“Poredeen“), a wholly owned subsidiary within the TauRx Pharmaceuticals Ltd group of companies (“TauRx”). Immuno Cure is a biotechnology group based in Hong Kong Science Park also committed to advancing healthcare solutions.
About LUCIDITY:
LUCIDITY is the only late-stage clinical trial specifically targeting the tau pathology of Alzheimer’s Disease.
Aggregation of abnormal tau protein is one of the hallmark pathologies. Tau aggregation and the subsequent formation of tau tangles disrupt neuronal function, a process that begins many years before symptoms of dementia are seen. Tau pathology correlates strongly with Alzheimer’s severity and the clinical decline (loss of memory and ability to care for one’s self) commonly seen in people with Alzheimer’s.
The LUCIDITY trial is designed to confirm the efficacy and safety of HMTM* (Hydromethylthionine Mesylate) to support regulatory submission as the first disease modifying tau targeting treatment for Mild Cognitive Impairment and Mild-to-Moderate stages of Alzheimer’s disease.
*Previously also abbreviated to LMTM and LMTX.
For more details, please click: https://taurx.com/the-science/clinical-trials
About Immuno Cure and ICB:
Immuno Cure is a clinical stage biotechnology group based in the Hong Kong Science Park, focusing on research and development of immunotherapies for cancers, inflammatory and infectious diseases based on its patented PD-1-enhanced DNA vaccine and Anti-Δ42PD1 Antibody platforms; with two DNA vaccine candidates currently in clinical trials. ICB is a member of the Immuno Cure Group, dedicated to providing professional services with innovative pharmaceutical therapies.
For more details, please click here: www.immunocure.hk
